Market revenue in 2023 | USD 14.7 million |
Market revenue in 2030 | USD 24.9 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Oxidized regenerated cellulose-based hemostats |
Fastest growing segment | Combination Hemostats |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Thrombin-based Hemostats, Oxidized Regenerated Cellulose-based Hemostats, Combination Hemostats |
Key market players worldwide | Johnson & Johnson, Integra Lifesciences Holdings Corp, Pfizer Inc, Becton Dickinson & Co, Medtronic PLC, Baxter International Inc, Stryker Corp, Artivion Inc, B. Braun |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemostats market will help companies and investors design strategic landscapes.
Oxidized regenerated cellulose-based hemostats was the largest segment with a revenue share of 48.3% in 2023. Horizon Databook has segmented the Kuwait hemostats market based on thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait hemostats market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait hemostats market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account